Loading…
MyCode is a DNA sequencing program by Geisinger that analyzes the DNA of consenting participants to identify genetic risks for certain health conditions, enabling earlier diagnosis and treatment. The program has enrolled over 340,000 participants and aims to offer every Geisinger patient the opportunity to join.
AI named MyCode (MyCode Genomic Screening and Counseling Program) in December 2025.